國家衛生研究院 NHRI:Item 3990099045/7551
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 860260      線上人數 : 458
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/7551


    題名: Incidence,life expectancy and prognostic factors of cancer patients under prolonged mechanical ventilation: A nationwide analysis of 5,138 cases during 1998-2007
    作者: Shih, CY;Hung, MC;Lu, HM;Chen, L;Huang, SJ;Wang, JD
    貢獻者: Division of Health Services and Preventive Medicine
    摘要: INTRODUCTION: This study is aimed at determining incidence, survival rate, life expectancy, quality-adjusted life expectancy (QALE), and prognostic factors in cancer patients with different organ-systems undergoing prolonged mechanical ventilation (PMV). METHODS: We used data from the National Health Insurance Research Database (NHIRD) of Taiwan, from 1998 to 2007, linked with the National Mortality Registry to ascertain mortality. Subjects who received PMV, defined as having undergone mechanical ventilation continually for longer than 21 days, were enrolled. The incidences of cancer patients requiring PMV were calculated with the exception of multiple cancers. The life expectancies and QALE of different types of cancer were estimated. Quality of life data were taken from a sample of 142 patients under PMV. A multivariable proportional hazard model was constructed to assess the effect of different prognostic factors, including age, gender, types of cancer, metastasis, comorbidities, and hospital levels. RESULTS: Among 9011 cancer patients receiving mechanical ventilation for more than seven days, 5138 undergoing PMV revealed a median survival of 1.37 (interquartile range [IQR], 0.50-4.57) months and a one-year survival rate of 14.3% (95% confidence interval [CI], 13.3-15.3%). The incidence of PMV was 10.4 per 100 ICU admissions. Head and neck cancer patients seemed to survive the longest. The overall life expectancy was 1.21 years with estimated QALE ranging from 0.17 to 0.37 quality-adjusted life years for patients with poor and partial cognition, respectively. Cancer of liver (hazard ratio [HR], 1.55; 95%CI, 1.34-1.78), lung (HR, 1.45; 95%CI, 1.30-1.41), and metastasis (HR, 1.53; 95%CI, 1.42-1.65) independently were found to predict shorter survival. CONCLUSIONS: Cancer patients requiring PMV had poor long-term outcomes. Palliative care should be considered early in these patients, especially when metastasis has occurred.
    日期: 2013-07-22
    關聯: Critical Care. 2013 Jul 22;17(4):Article number R144.
    Link to: http://dx.doi.org/10.1186/cc12823
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1364-8535&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000331539700018
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84880335779
    顯示於類別:[陳麗光] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    BMC2013100701.pdf261KbAdobe PDF446檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋